drugset / Trial / NCT00700037

Change in Plaque Characteristics With Atorvastatin

NCT00700037 ↗

Phase 4 Completed 70 enrolled Wakayama Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

To examine effects of intensive lipid lowering therapy with atorvastatin on stabilization of coronary plaque by using optical coherence tomography (OCT) in patients with acute coronary syndrome.

Timeline

Start
2009-08
Primary completion
2012-02
Completion
2012-02

Outcome

Met primary endpoint

paper The increase in fibrous cap thickness was significantly greater with 20 mg/day compared with 5 mg/day of atorvastatin (69% vs. 17%; p < 0.001). PMID 25456755 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 5 mg —
Subject Atorvastatin Small molecule 20 mg —